Approvals/CIMA-AEMPS/AVANCORT 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL

Approved

STANDARD

AVANCORT 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL

Laboratorios Cinfa S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 52f03b26f436accf
Drug Cima Aemps Name: AVANCORT 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL
Register Number: 89779
Holder Company Name: Laboratorios Cinfa S.A.
Marketing Company Name: Laboratorios Cinfa S.A.
Authorization Date: 2024-08-21
Dosage Form: SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose: 27,5 MICROGRAMOS/PULVERIZACIÓN
Route Of Administration: VÍA NASAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Laboratorios Cinfa S.A.

FLUTICASONA FUROATO

27,5 µg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 21, 2024

Approval ID

52f03b26f436accf

Type

Standard